- Home
- FRPH vs KMDA Comparison
FRPH vs KMDA Comparison
Compare FRPH & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- KMDA
- Stock Information
- Founded
- FRPH 1986
- KMDA 1990
- Country
- FRPH United States
- KMDA Israel
- Employees
- FRPH N/A
- KMDA N/A
- Industry
- FRPH Real Estate
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- KMDA Health Care
- Exchange
- FRPH Nasdaq
- KMDA Nasdaq
- Market Cap
- FRPH 519.9M
- KMDA 443.4M
- IPO Year
- FRPH N/A
- KMDA N/A
- Fundamental
- Price
- FRPH $27.22
- KMDA $7.72
- Analyst Decision
- FRPH
- KMDA Strong Buy
- Analyst Count
- FRPH 0
- KMDA 2
- Target Price
- FRPH N/A
- KMDA $13.00
- AVG Volume (30 Days)
- FRPH 52.4K
- KMDA 55.4K
- Earning Date
- FRPH 08-06-2025
- KMDA 08-13-2025
- Dividend Yield
- FRPH N/A
- KMDA 2.59%
- EPS Growth
- FRPH 12.32
- KMDA 31.21
- EPS
- FRPH 0.36
- KMDA 0.28
- Revenue
- FRPH $31,576,000.00
- KMDA $167,235,000.00
- Revenue This Year
- FRPH N/A
- KMDA $14.51
- Revenue Next Year
- FRPH N/A
- KMDA $9.31
- P/E Ratio
- FRPH $75.74
- KMDA $28.31
- Revenue Growth
- FRPH 4.58
- KMDA 11.83
- 52 Week Low
- FRPH $25.37
- KMDA $5.08
- 52 Week High
- FRPH $33.00
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- FRPH 51.48
- KMDA 53.97
- Support Level
- FRPH $27.20
- KMDA $7.64
- Resistance Level
- FRPH $27.26
- KMDA $7.91
- Average True Range (ATR)
- FRPH 0.48
- KMDA 0.18
- MACD
- FRPH 0.04
- KMDA -0.02
- Stochastic Oscillator
- FRPH 70.83
- KMDA 50.00
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.